Abstract
Objective: Coronavirus Disease-2019 (COVID-19) is a pandemic outbreak in the world and is the leading cause of Severe Acute Respiratory Syndrome (SARS).
Methods: Currently, many drugs/therapies have been tested for COVID-19, which responded sub- -optimally to the patients. Remdesivir is an RNA polymerase inhibitor that found promising results in ongoing clinical trials and shows a faster recovery rate in COVID-19 patients. Currently, USFDA approves for emergent use of this drug in severe COVID-19 patients. Results: In this review, we discussed a brief overview of biopharmaceutical and pharmacological aspects of Remdesivir. Moreover, the ongoing regulatory status of Remdesivir by official bodies has also been described.Keywords: Remdesivir, COVID-19, USFDA, SARS, WHO, RNA polymerase inhibitor.
Coronaviruses
Title:Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope
Volume: 2 Issue: 8
Author(s): Kuldeep Singh, Dilpreet Singh* Karan Razdan
Affiliation:
- Department of Pharmaceutics, ISF College of Pharmacy, Punjab,India
Keywords: Remdesivir, COVID-19, USFDA, SARS, WHO, RNA polymerase inhibitor.
Abstract: Objective: Coronavirus Disease-2019 (COVID-19) is a pandemic outbreak in the world and is the leading cause of Severe Acute Respiratory Syndrome (SARS).
Methods: Currently, many drugs/therapies have been tested for COVID-19, which responded sub- -optimally to the patients. Remdesivir is an RNA polymerase inhibitor that found promising results in ongoing clinical trials and shows a faster recovery rate in COVID-19 patients. Currently, USFDA approves for emergent use of this drug in severe COVID-19 patients. Results: In this review, we discussed a brief overview of biopharmaceutical and pharmacological aspects of Remdesivir. Moreover, the ongoing regulatory status of Remdesivir by official bodies has also been described.Export Options
About this article
Cite this article as:
Singh Kuldeep , Singh Dilpreet *, Razdan Karan , Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope, Coronaviruses 2021; 2 (8) : e260721189256 . https://dx.doi.org/10.2174/2666796701999201218141652
DOI https://dx.doi.org/10.2174/2666796701999201218141652 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Inhibition of Platelet Reactivity. Clinical and Pharmacodynamic Effects
Current Vascular Pharmacology Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery Reproductive Toxicology of Environmental Toxicants: Emerging Issues and Concerns
Current Pharmaceutical Design Molecular Design and QSARs/QSPRs with Molecular Descriptors Family
Current Computer-Aided Drug Design <i>Bacopa monnieri</i> for Disorders Affecting Brain: Current Perspectives
Current Topics in Medicinal Chemistry N-Acetyl Cysteine Attenuates the Sarcopenia and Muscle Apoptosis Induced by Chronic Liver Disease
Current Molecular Medicine Diaryl Urea: A Privileged Structure in Anticancer Agents
Current Medicinal Chemistry Biological Evaluation of Indole Appended Triazolothiadiazepine Conjugates as Potent Anticancer Agents
Current Bioactive Compounds A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19)
Infectious Disorders - Drug Targets CDK9 a Potential Target for Drug Development
Medicinal Chemistry Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion
Current Drug Targets Epigenetic Programming of Adipose Tissue in the Progeny of Obese Dams
Current Genomics Impact of Headache Frequency and Sleep on Migraine Patients During the COVID-19 Pandemic
Current Neurovascular Research MTDL Design Strategy in the Context of Alzheimers Disease: From Lipocrine to Memoquin and Beyond
Current Pharmaceutical Design Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp
Current Pharmaceutical Design 2-Aminoimidazole, Glycociamidine and 2-Thiohydantoin-Marine Alkaloids as Molecular Inspirations for the Development of Lead Structures
Current Drug Targets Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)
Current Topics in Medicinal Chemistry Review Camptothecin: Current Perspectives
Current Medicinal Chemistry Mesoionic Oxatriazoles (MOTA): NO-Donating Characteristics and Pharmacology
Current Pharmaceutical Design